As of 1 March 2013, anyone who subscribes to Medicine Prices for companies has access to preliminary data on Medicine Prices. Preliminary data will be made available 11 and 10 days prior to the effective date of a new medicine price period.
This follows from the Danish executive order no. 59 of 29 January 2009 on medicine prices and supply conditions as amended by Danish executive order no. 201 of 27 February 2013. From 1 March 2013, the following applies:
- 11 days prior to the start of a new price period, preliminary data on prices of new packages and changes to product range are published.
- 10 days prior to the start of a new price period, the data appearing from section 5(1)(ii) to (x) of the Danish executive order no. 59 of 29 January 2009 on medicinal prices and supply conditions:
"(ii) the marketed package sizes of medicinal products covered by section 1
(iii) substitutability at package level,
(iv) warning about effects on the ability to drive,
(v) dispensing status,
(vi) restrictions on how many packages may be dispensed per transaction when sold outside pharmacies,
(vii) medical specialities required for the prescriber to prescribe the medicinal product,
(viii) reimbursement price, including any unit reimbursement price,
(ix) package combinations and
(x) information about A, B or C price."
Please note that these published data are preliminary and may change before entering into force on Medicine Prices.
Furthermore, the amendment implies that the Danish Health and Medicines Authority will no longer send the preliminary data to specific stakeholders. Anyone interested can instead access the information via Medicine Prices for Companies Anyone can subscribe to Medicine Prices for companies.
The preliminary data will be made available in the folder "lms > FORELØBIG" at ftp.dkma.dk. Further information on how to download these files can be found in the "Guide to downloading LMS files from ftp.dkma.dk" on www.erhverv.medicinpriser.dk .
The first upload of preliminary data took place on 7 and 8 March 2013 and concern the medicine price period starting on 18 March 2013.